Agenus clinical trials we track

Check company identity source

Phase 2 5 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 4 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Objective Response Rate Description: Objective response rate will be determined using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1). Time frame: First dose through up to 3 months. After: Measure: Objective Response Rate Description: Objective response rate will be determined using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1). Time frame: Up to 40 months.

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Feb 2028. After: 27 Apr 2026.

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 212 participants (planned). After: 211 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Aug 2025. After: 26 Mar 2025.

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source